Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study.

Weiss B, Bujanover Y, Yahav Y, Vilozni D, Fireman E, Efrati O.

Pediatr Pulmonol. 2010 Jun;45(6):536-40. doi: 10.1002/ppul.21138.

PMID:
20503277
2.

The relation between age and time to maximal bronchoconstriction following exercise in children.

Vilozni D, Szeinberg A, Barak A, Yahav Y, Augarten A, Efrati O.

Respir Med. 2009 Oct;103(10):1456-60. doi: 10.1016/j.rmed.2009.04.028. Epub 2009 Jun 3.

3.

Forced inspiratory flow volume curve in healthy young children.

Vilozni D, Efrati O, Barak A, Yahav Y, Augarten A, Bentur L.

Pediatr Pulmonol. 2009 Feb;44(2):105-11. doi: 10.1002/ppul.20835.

PMID:
19142889
4.

Flexible bronchoscopy and bronchoalveolar lavage in pediatric patients with lung disease.

Efrati O, Sadeh-Gornik U, Modan-Moses D, Barak A, Szeinberg A, Vardi A, Paret G, Toren A, Vilozni D, Yahav Y.

Pediatr Crit Care Med. 2009 Jan;10(1):80-4. doi: 10.1097/PCC.0b013e31819372ea.

PMID:
19057431
5.

Nasal potential difference in non-classic cystic fibrosis-long term follow up.

Jaron R, Yaakov Y, Rivlin J, Blau H, Bentur L, Yahav Y, Kerem E, Bibi H, Picard E, Wilschanski M.

Pediatr Pulmonol. 2008 Jun;43(6):545-9. doi: 10.1002/ppul.20807.

PMID:
18433042
6.

Cystic fibrosis transmembrane conductance regulator ion channel function testing in recurrent acute pancreatitis.

Segal I, Yaakov Y, Adler SN, Blau H, Broide E, Santo M, Yahav Y, Klar A, Lerner A, Aviram M, Ellis I, Mountford R, Shteyer E, Kerem E, Wilschanski M.

J Clin Gastroenterol. 2008 Aug;42(7):810-4. doi: 10.1097/MCG.0b013e318156617c.

PMID:
18360295
7.

Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel.

Levy I, Grisaru-Soen G, Lerner-Geva L, Kerem E, Blau H, Bentur L, Aviram M, Rivlin J, Picard E, Lavy A, Yahav Y, Rahav G.

Emerg Infect Dis. 2008 Mar;14(3):378-84. doi: 10.3201/eid1403.061405.

8.

The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.

Augarten A, Ben Tov A, Madgar I, Barak A, Akons H, Laufer J, Efrati O, Aviram M, Bentur L, Blau H, Paret G, Wilschanski M, Kerem BS, Yahav Y.

Eur J Gastroenterol Hepatol. 2008 Mar;20(3):164-8. doi: 10.1097/MEG.0b013e3282f36d04.

PMID:
18301294
9.

Reproducibility of nasal potential difference measurements in cystic fibrosis.

Yaakov Y, Kerem E, Yahav Y, Rivlin J, Blau H, Bentur L, Aviram M, Picard E, Bdolah-Abram T, Wilschanski M.

Chest. 2007 Oct;132(4):1219-26. Epub 2007 Sep 21.

PMID:
17890478
10.

N-terminal pro B-type natriuretic peptide (N-BNP) levels in cystic fibrosis patients.

Ben Tov A, Paret G, Sela BA, Blau H, Hegesh J, Efrati O, Yahav Y, Augarten A.

Pediatr Pulmonol. 2007 Aug;42(8):699-703.

PMID:
17588252
11.

Exercise challenge test in 3- to 6-year-old asthmatic children.

Vilozni D, Bentur L, Efrati O, Barak A, Szeinberg A, Shoseyov D, Yahav Y, Augarten A.

Chest. 2007 Aug;132(2):497-503. Epub 2007 Jun 15.

PMID:
17573494
12.

Spirometry in early childhood in cystic fibrosis patients.

Vilozni D, Bentur L, Efrati O, Minuskin T, Barak A, Szeinberg A, Blau H, Picard E, Kerem E, Yahav Y, Augarten A.

Chest. 2007 Feb;131(2):356-61.

PMID:
17296633
13.

Lung transplantation in patients with cystic fibrosis: the Israeli experience.

Prais D, Raviv Y, Shitrit D, Yellin A, Sahar G, Bendayan D, Yahav Y, Efrati O, Reichart N, Blau H, Bakal I, Buchman G, Saute M, Vidne B, Kramer MR.

Isr Med Assoc J. 2006 Jun;8(6):396-9.

14.

Long term nutritional rehabilitation by gastrostomy in Israeli patients with cystic fibrosis: clinical outcome in advanced pulmonary disease.

Efrati O, Mei-Zahav M, Rivlin J, Kerem E, Blau H, Barak A, Bujanover Y, Augarten A, Cochavi B, Yahav Y, Modan-Moses D.

J Pediatr Gastroenterol Nutr. 2006 Feb;42(2):222-8.

PMID:
16456419
15.

Effect of low altitude at the Dead Sea on exercise capacity and cardiopulmonary response to exercise in cystic fibrosis patients with moderate to severe lung disease.

Falk B, Nini A, Zigel L, Yahav Y, Aviram M, Rivlin J, Bentur L, Avital A, Dotan R, Blau H.

Pediatr Pulmonol. 2006 Mar;41(3):234-41.

PMID:
16429430
16.

The role of computer games in measuring spirometry in healthy and "asthmatic" preschool children.

Vilozni D, Barak A, Efrati O, Augarten A, Springer C, Yahav Y, Bentur L.

Chest. 2005 Sep;128(3):1146-55.

PMID:
16162700
17.

Methacholine bronchial provocation measured by spirometry versus wheeze detection in preschool children.

Bentur L, Beck R, Elias N, Barak A, Efrati O, Yahav Y, Vilozni D.

BMC Pediatr. 2005 Jun 28;5:19.

18.

Pregnancies and outcome in women with cystic fibrosis.

Barak A, Dulitzki M, Efrati O, Augarten A, Szeinberg A, Reichert N, Modan D, Weiss B, Miller M, Katzanelson D, Yahav Y.

Isr Med Assoc J. 2005 Feb;7(2):95-8.

19.

Trampoline use as physiotherapy for cystic fibrosis patients.

Barak A, Wexler ID, Efrati O, Bentur L, Augarten A, Mussaffi H, Avital A, Rivlin J, Aviram M, Yahav Y, Kerem E.

Pediatr Pulmonol. 2005 Jan;39(1):70-3. Review.

PMID:
15532080
20.

Long-term non-invasive positive pressure ventilation among cystic fibrosis patients awaiting lung transplantation.

Efrati O, Modan-Moses D, Barak A, Boujanover Y, Augarten A, Szeinberg AM, Levy I, Yahav Y.

Isr Med Assoc J. 2004 Sep;6(9):527-30.

21.

Familial concordance of phenotype and microbial variation among siblings with CF.

Picard E, Aviram M, Yahav Y, Rivlin J, Blau H, Bentur L, Avital A, Villa Y, Schwartz S, Kerem B, Kerem E.

Pediatr Pulmonol. 2004 Oct;38(4):292-7.

PMID:
15334505
22.

Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests.

Augarten A, Berman H, Aviram M, Diver-Habber A, Akons H, Ben Tur L, Blau H, Kerem E, Rivlin J, Katznelson D, Szeinberg A, Kerem BS, Theodor L, Paret G, Yahav Y.

Clin Exp Med. 2003 Sep;3(2):119-23.

PMID:
14598187
23.

Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.

Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L, Rivlin J, Aviram M, Bdolah-Abram T, Bebok Z, Shushi L, Kerem B, Kerem E.

N Engl J Med. 2003 Oct 9;349(15):1433-41.

24.

Oligohydrosis and hyperthermia: pilot study of a novel topiramate adverse effect.

Ben-Zeev B, Watemberg N, Augarten A, Brand N, Yahav Y, Efrati O, Topper L, Blatt I.

J Child Neurol. 2003 Apr;18(4):254-7.

PMID:
12760427
25.

13C-urea breath test to validate eradication of Helicobacter pylori in an Israeli population.

Gal E, Abuksis G, Fraser G, Koren R, Shmueli C, Yahav Y, Niv Y.

Isr Med Assoc J. 2003 Feb;5(2):98-100.

26.

Reversal of digital clubbing after lung transplantation in cystic fibrosis patients: a clue to the pathogenesis of clubbing.

Augarten A, Goldman R, Laufer J, Szeinberg A, Efrati O, Barak A, Miller MS, Yahav Y.

Pediatr Pulmonol. 2002 Nov;34(5):378-80.

PMID:
12357483
27.

Hyperechogenic bowel loops and meconium ileus in a fetus carrying the D1152H and G542X cystic fibrosis CFTR mutations.

Orgad S, Berkenstadt M, Achiron R, Yahav Y, Gazit E, Barkai G, Loewenthal R.

Prenat Diagn. 2002 Jul;22(7):636-7. No abstract available.

PMID:
12124706
28.

Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients.

Augarten A, Akons H, Aviram M, Bentur L, Blau H, Picard E, Rivlin J, Miller MS, Katznelson D, Szeinberg A, Shmilovich H, Paret G, Laufer J, Yahav Y.

Pediatr Transplant. 2001 Oct;5(5):339-42.

PMID:
11560752
29.

Nasal potential difference measurements in patients with atypical cystic fibrosis.

Wilschanski M, Famini H, Strauss-Liviatan N, Rivlin J, Blau H, Bibi H, Bentur L, Yahav Y, Springer H, Kramer MR, Klar A, Ilani A, Kerem B, Kerem E.

Eur Respir J. 2001 Jun;17(6):1208-15.

30.

Serum lipase levels as a diagnostic marker in cystic fibrosis patients with normal or borderline sweat tests.

Augarten A, Shmilovich H, Doolman R, Aviram M, Akons H, Ben Tur L, Blau H, Kerem E, Rivlin J, Sela BA, Szeinberg A, Yahav Y.

Pediatr Pulmonol. 2000 Oct;30(4):320-3.

PMID:
11015133
31.

Lundh meal: a single non-invasive challenge test for evaluation of exocrine and endocrine pancreatic function in cystic fibrosis patients.

Augarten A, Dubenbaum L, Yahav Y, Katznelson D, Szeinberg A, Blank A, Sack J.

Int J Clin Lab Res. 1999;29(3):114-6.

PMID:
10592108
32.

Serum lipase levels pre and post Lundh meal: evaluation of exocrine pancreatic status in cystic fibrosis.

Augarten A, Katznelson D, Dubenbaum L, Doolman R, Sela BA, Lusky A, Szeinberg A, Kerem BS, Paret G, Gazit E, Sack J, Yahav Y.

Int J Clin Lab Res. 1998;28(4):226-9.

PMID:
9879495
33.

A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype.

Kerem E, Nissim-Rafinia M, Argaman Z, Augarten A, Bentur L, Klar A, Yahav Y, Szeinberg A, Hiba O, Branski D, Corey M, Kerem B.

Pediatrics. 1997 Sep;100(3):E5.

PMID:
9271620
34.

The critical first six months in cystic fibrosis: a syndrome of severe bronchiolitis.

Katznelson D, Szeinberg A, Augarten A, Yahav Y.

Pediatr Pulmonol. 1997 Aug;24(2):134-6; discussion 159-61.

PMID:
9292909
35.

Nephrotic syndrome and fibrillary glomerulonephritis.

Laufer J, Augarten A, Szeinberg A, Rapoport J, Katzenelson D, Yahav Y.

J Intern Med. 1997 Jul;242(1):83-6.

36.

A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations.

Kerem E, Rave-Harel N, Augarten A, Madgar I, Nissim-Rafinia M, Yahav Y, Goshen R, Bentur L, Rivlin J, Aviram M, Genem A, Chiba-Falek O, Kraemer MR, Simon A, Branski D, Kerem B.

Am J Respir Crit Care Med. 1997 Jun;155(6):1914-20.

PMID:
9196095
37.

The value of anti-Helicobacter pylori IgG antibodies in establishing eradication of infection in children.

Fradkin A, Yahav Y, Diver-Haber A, Weisselberg B, Jonas A.

Isr J Med Sci. 1997 Feb;33(2):87-92.

PMID:
9254868
38.

[New therapeutic modalities for pulmonary disease in cystic fibrosis].

Virgilis D, Augarten A, Szeinberg A, Yahav Y.

Harefuah. 1995 Dec 15;129(12):569-72. Review. Hebrew. No abstract available.

PMID:
8682360
39.

[Neurological symptoms associated with vitamin E deficiency].

Sela BA, Shorer Z, Doolman R, Yahav Y, Brill G, Carmi R, Shahar E.

Harefuah. 1995 Dec 15;129(12):539-42, 615. Hebrew.

PMID:
8682350
40.

Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel.

Kerem E, Kalman YM, Yahav Y, Shoshani T, Abeliovich D, Szeinberg A, Rivlin J, Blau H, Tal A, Ben-Tur L, et al.

Hum Genet. 1995 Aug;96(2):193-7.

PMID:
7635469
41.

HLA-B5 in the diagnosis of Behcet's disease.

Augarten A, Yahav Y, Szeinberg A, Fradkin A, Gazit E, Laufer J.

J Med. 1995;26(3-4):133-8.

PMID:
8558094
42.

Congenital bilateral absence of vas deferens in the absence of cystic fibrosis.

Augarten A, Yahav Y, Kerem BS, Halle D, Laufer J, Szeinberg A, Dor J, Mashiach S, Gazit E, Madgar I.

Lancet. 1994 Nov 26;344(8935):1473-4.

PMID:
7968122
43.

Similar levels of mRNA from the W1282X and the delta F508 cystic fibrosis alleles, in nasal epithelial cells.

Shoshani T, Kerem E, Szeinberg A, Augarten A, Yahav Y, Cohen D, Rivlin J, Tal A, Kerem B.

J Clin Invest. 1994 Apr;93(4):1502-7.

44.

Correlation between genotype and phenotype in patients with cystic fibrosis.

Augarten A, Kerem BS, Kerem E, Gazit E, Yahav Y.

N Engl J Med. 1994 Mar 24;330(12):866. No abstract available.

PMID:
8114851
45.

Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C-->T mutation.

Augarten A, Kerem BS, Yahav Y, Noiman S, Rivlin Y, Tal A, Blau H, Ben-Tur L, Szeinberg A, Kerem E, et al.

Lancet. 1993 Jul 3;342(8862):25-6.

PMID:
8100293
46.

D-lactic acidosis: a treatable encephalopathy in pediatric patients.

Gurevitch J, Sela B, Jonas A, Golan H, Yahav Y, Passwell JH.

Acta Paediatr. 1993 Jan;82(1):119-21.

PMID:
8453209
47.

A new mutation in the CFTR gene, composed of two adjacent DNA alterations, is a common cause of cystic fibrosis among Georgian Jews.

Shoshani T, Berkun Y, Yahav Y, Augarten A, Bashan N, Rivlin Y, Gazit E, Sereth H, Kerem E, Kerem BS.

Genomics. 1993 Jan;15(1):236-7. No abstract available.

PMID:
7679367
48.

Cystic fibrosis manifested as undescended testis and absence of vas deferens.

Goshen R, Kerem E, Shoshani T, Kerem BS, Feigin E, Zamir O, Yahav Y.

Pediatrics. 1992 Dec;90(6):982-3. No abstract available.

PMID:
1359500
49.

Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease.

Shoshani T, Augarten A, Gazit E, Bashan N, Yahav Y, Rivlin Y, Tal A, Seret H, Yaar L, Kerem E, et al.

Am J Hum Genet. 1992 Jan;50(1):222-8.

50.

Immediate effect of various treatments on lung function in infants with cystic fibrosis.

Maayan C, Bar-Yishay E, Yaacobi T, Marcus Y, Katznelson D, Yahav Y, Godfrey S.

Respiration. 1989;55(3):144-51. Review.

PMID:
2682864

Supplemental Content

Support Center